The medication helps treat pulmonary arterial hypertension by diminishing symptoms linked to exercise. It is also used to reduce the rate of clinical deterioration among patients transitioning from epoprostenol.
The lot of the treprostinil injection 20 milligram per 20 milliliter solution was distributed to hospitals and wholesalers in summer 2022, according to the FDA.
A solution contaminated with a particulate matter can cause local irritation, swelling or blocked blood vessels in the heart, lungs or brain, which can lead to stroke or even death. No adverse events have been reported.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
